SONN
Price
$1.15
Change
+$0.02 (+1.77%)
Updated
Jun 26 closing price
Capitalization
3.64M
TPST
Price
$7.09
Change
-$0.06 (-0.84%)
Updated
Jun 26 closing price
Capitalization
26.11M
41 days until earnings call
Interact to see
Advertisement

SONN vs TPST

Header iconSONN vs TPST Comparison
Open Charts SONN vs TPSTBanner chart's image
Sonnet BioTherapeutics Holdings
Price$1.15
Change+$0.02 (+1.77%)
Volume$41.14K
Capitalization3.64M
Tempest Therapeutics
Price$7.09
Change-$0.06 (-0.84%)
Volume$55.81K
Capitalization26.11M
SONN vs TPST Comparison Chart in %
Loading...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SONN vs. TPST commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SONN is a Buy and TPST is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (SONN: $1.15 vs. TPST: $7.09)
Brand notoriety: SONN and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SONN: 98% vs. TPST: 42%
Market capitalization -- SONN: $3.64M vs. TPST: $26.11M
SONN [@Biotechnology] is valued at $3.64M. TPST’s [@Biotechnology] market capitalization is $26.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SONN’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • SONN’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, TPST is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SONN’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • SONN’s TA Score: 4 bullish, 3 bearish.
  • TPST’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, SONN is a better buy in the short-term than TPST.

Price Growth

SONN (@Biotechnology) experienced а -1.29% price change this week, while TPST (@Biotechnology) price change was +2.75% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

SONN is expected to report earnings on May 13, 2025.

TPST is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TPST($26.1M) has a higher market cap than SONN($3.64M). SONN YTD gains are higher at: -21.233 vs. TPST (-34.645). SONN has higher annual earnings (EBITDA): -13.69M vs. TPST (-43.32M). TPST has more cash in the bank: 21.5M vs. SONN (2.06M). SONN has less debt than TPST: SONN (90.4K) vs TPST (13.1M). SONN has higher revenues than TPST: SONN (1M) vs TPST (0).
SONNTPSTSONN / TPST
Capitalization3.64M26.1M14%
EBITDA-13.69M-43.32M32%
Gain YTD-21.233-34.64561%
P/E Ratio0.29N/A-
Revenue1M0-
Total Cash2.06M21.5M10%
Total Debt90.4K13.1M1%
FUNDAMENTALS RATINGS
SONN vs TPST: Fundamental Ratings
SONN
TPST
OUTLOOK RATING
1..100
2124
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8665
P/E GROWTH RATING
1..100
9790
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (49) in the Pharmaceuticals Major industry is in the same range as SONN (52) in the null industry. This means that TPST’s stock grew similarly to SONN’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SONN (100) in the null industry. This means that TPST’s stock grew similarly to SONN’s over the last 12 months.

TPST's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as SONN (100) in the null industry. This means that TPST’s stock grew similarly to SONN’s over the last 12 months.

TPST's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as SONN (86) in the null industry. This means that TPST’s stock grew similarly to SONN’s over the last 12 months.

TPST's P/E Growth Rating (90) in the Pharmaceuticals Major industry is in the same range as SONN (97) in the null industry. This means that TPST’s stock grew similarly to SONN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SONNTPST
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LSF6.310.19
+3.10%
Laird Superfood
GPN78.240.52
+0.67%
Global Payments
CRAI186.011.11
+0.60%
CRA International
HP15.530.05
+0.32%
Helmerich & Payne
NGNE16.57-0.31
-1.84%
Neurogene

SONN and

Correlation & Price change

A.I.dvisor tells us that SONN and DWTX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and DWTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
+1.77%
DWTX - SONN
27%
Poorly correlated
-0.63%
MCRB - SONN
26%
Poorly correlated
N/A
IGMS - SONN
26%
Poorly correlated
+0.83%
PHAR - SONN
25%
Poorly correlated
+0.24%
PRME - SONN
25%
Poorly correlated
+9.50%
More

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
-0.84%
PHIO - TPST
49%
Loosely correlated
+1.84%
ABCZF - TPST
48%
Loosely correlated
N/A
RXRX - TPST
38%
Loosely correlated
+4.65%
ARCT - TPST
38%
Loosely correlated
+3.30%
IMNM - TPST
38%
Loosely correlated
+1.27%
More